Table 1 Characteristics of the Study Population
| Â | Mortality | |
|---|---|---|
| Â | Yes (n = 155) | No (n = 732) |
Characteristics | Mean (SD) or % (Number) | Mean (SD) or % (Number) |
Social and demographic variables | Â | Â |
Age, yrs | 35.97 (8.49) | 31.35 (8.84) |
Females | 40.00% (62) | 32.10% (235) |
Karnofsky Score | 71.74 (9.54) | 75.17 (8.41) |
Shillings* spent on food/person/day (quartiles) | ||
   ≤ 250 | 28.37% (40) | 23.14% (149) |
   251-499 | 26.24% (37) | 26.40% (170) |
   500-750 | 26.24% (37) | 27.17% (175) |
   >750 | 19.15% (27) | 23.29% (150) |
TB related | Â | Â |
AFB Smear Result positive at baseline | 96.75% (149) | 94.12% (688) |
AFB Culture positive at baseline | 66.67% (44) | 68.82% (287) |
Laboratory Results | Â | Â |
Baseline Hemoglobin, g/dL | 9.59 (1.59) | 10.59 (1.82) |
HIV- or Immune function related | Â | Â |
HIV infected | 90.32% (140) | 45.22% (331) |
Baseline WHO HIV stage | Â | Â |
   3 | 85.96% (98) | 93.48% (215) |
   4 | 14.04% (16) | 6.52% (15) |
Baseline CD4 cell count/μL | 238.15 (302.25) | 564.04 (288.86) |
Baseline CD3 cell count/μL | 1086.23 (605.21) | 1232.42 (501.09) |
Baseline CD8 cell count/μL | 785.61 (454.56) | 601.85 (383.09) |
CD4/CD8 Ratio | 0.39 (0.71) | 1.30 (0.90) |
Log(10) viral load | 5.11 (0.66) | 4.38 (0.99) |
   Q1 | 6.45% (10) | 11.61% (85) |
   Q2 | 14.19% (22) | 9.97% (73) |
   Q3 | 18.06% (28) | 9.15% (67) |
   Q4 | 34.84% (54) | 5.60% (41) |
Clinical signs and symptoms | Â | Â |
Diarrhea | 9.45% (12) | 10.12% (58) |
Fatigue | 71.65% (91) | 66.32% (380) |
Fever | 55.12% (70) | 64.22% (368) |
Nausea/Vomiting | 5.51% (7) | 8.90% (51) |
Skin Rash | 20.47% (26) | 8.90% (51) |
Oral thrush | 12.60% (16) | 1.40% (8) |
Weight loss | 81.89% (104) | 80.63% (462) |
Extrapulmonary TB | 1.57% (2) | 2.44% (14) |
Anthropometry | Â | Â |
BMI at enrolment, kg/m2 | 19.31 (3.04) | 19.10 (2.64) |
MUAC at enrolment, cm | 23.25 (2.85) | 23.25 (2.61) |